title: Identification of the Factors Responsible for the Selective in vitro Cytotoxic Activity of Isoprenylated Coumarin Derivatives under Nutrient-deprived Conditions.
abstract: Pancreatic cancer is one of the most devastating forms of human cancer. The lack of effective clinical treatments for pancreatic cancer has led to one of the lowest five-year survival rates among all cancers. Recently, our laboratory has developed a novel series of isoprenylated coumarin derivatives that have exhibited anti-pancreatic cancer activity exclusively under nutrient-deprived conditions. In this study, we report the effect of the various cell culture medium components on the preferential cytotoxicity of our lead isoprenylated coumarin compound against the pancreatic adenocarcinoma cell line PANC-1. In particular, our findings show a clear link between observed cytotoxicity and glucose deprivation, suggesting that our compound targets a salvage pathway when glycolysis is no longer an option for cancer cell survival. The cytotoxicity of our lead compound was also examined in vitro against two other pancreatic cancer cell lines, BxPC-3 and Capan-2 under both nutrient-rich and nutrient-deprived conditions.
authors.affiliation: 1. Department of Chemistry, Wellesley College, Wellesley, Massachusetts 02481, USA.
authors.forename: Hong
authors.initials: H
authors.lastname: Zhang
authors.affiliation: 1. Department of Chemistry, Wellesley College, Wellesley, Massachusetts 02481, USA.
authors.forename: Ronghao
authors.initials: R
authors.lastname: Zhou
authors.affiliation: 1. Department of Chemistry, Wellesley College, Wellesley, Massachusetts 02481, USA.
authors.forename: Maria
authors.initials: M
authors.lastname: Jun
authors.affiliation: 1. Department of Chemistry, Wellesley College, Wellesley, Massachusetts 02481, USA.
authors.forename: Alyssa F
authors.initials: AF
authors.lastname: Bacay
authors.affiliation: 1. Department of Chemistry, Wellesley College, Wellesley, Massachusetts 02481, USA.
authors.forename: Katherine
authors.initials: K
authors.lastname: Eyring
authors.affiliation: 2. Department of Biological Sciences, Wellesley College, Wellesley, Massachusetts 02481, USA.
authors.forename: Andrew
authors.initials: A
authors.lastname: Webb
authors.affiliation: 1. Department of Chemistry, Wellesley College, Wellesley, Massachusetts 02481, USA.
authors.forename: Dora
authors.initials: D
authors.lastname: Carrico-Moniz
keywords: anti-pancreatic cancer; isoprenylated coumarin derivatives
references.citation: Cancer Res. 2000 Nov 1;60(21):6201-7
references.pmid: 11085546
references.citation: Phytother Res. 2012 Dec;26(12):1920-6
references.pmid: 22447631
references.citation: Cancer Cell. 2012 Mar 20;21(3):327-9
references.pmid: 22439929
references.citation: Cancer Sci. 2004 Jun;95(6):547-52
references.pmid: 15182438
references.citation: Drug Des Devel Ther. 2013 Dec 18;8:39-47
references.pmid: 24379655
references.citation: Nat Rev Drug Discov. 2012 Sep;11(9):709-30
references.pmid: 22935804
references.citation: Oncologist. 2010;15(3):259-69
references.pmid: 20203172
references.citation: Bioorg Med Chem Lett. 2014 Oct 1;24(19):4654-8
references.pmid: 25205194
references.citation: Cancer Res. 2006 Feb 1;66(3):1751-7
references.pmid: 16452235
references.citation: Expert Opin Investig Drugs. 2012 Feb;21(2):143-52
references.pmid: 22217246
references.citation: Bioorg Med Chem Lett. 2006 Feb;16(3):581-3
references.pmid: 16288865
references.citation: Cancer Res. 2009 Jul 15;69(14 ):5820-8
references.pmid: 19584296
references.citation: Cancer Cell. 2012 Mar 20;21(3):297-308
references.pmid: 22439925
references.citation: N Engl J Med. 2014 Sep 11;371(11):1039-49
references.pmid: 25207767
references.citation: Cancer Sci. 2004 Aug;95(8):685-90
references.pmid: 15298733
references.citation: Bioorg Med Chem Lett. 2011 Oct 1;21(19):5770-3
references.pmid: 21880488
references.citation: Eur J Cancer. 2014 May;50(7):1382-90
references.pmid: 24503026